Newtag icon
Top Black Friday 2025 brands announced! What were the hottest products and categories?Download the report now 👉banner icon
Dr. Reddy's Laboratories

November 2025

  • Home
  • Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Market Share Analysis for November 2025

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.
Year Founded1984
Employees> 10001
Annual Revenue$25M - $50M
msnlabs.com
aurigeneservices.com
drreddys.com
Dr. Reddy's Laboratories
Showing Dr. Reddy's Laboratories's traffic and engagement information for its main website (including company regionals)
  • drreddys.com
    drreddys.com
  • msnlabs.com
    msnlabs.com
  • aurigeneservices.com
    aurigeneservices.com
See more website traffic and engagement information

Dr. Reddy's Laboratories Revenue up to November 2025 is 25M - 50M

revenue generated by Dr. Reddy's Laboratories top domains

Dr. Reddy's Laboratories top domains revenue over 3 years

Revenue for Dr. Reddy's Laboratories top domains

drreddys.comdrreddys.com25M - 50M
msnlabs.commsnlabs.com> 1B
See more with Sales Intelligence

Dr. Reddy's Laboratories Stock price in November 2025

Dr. Reddy's Laboratories stock is traded under the ticker #RDY. Below you can review Dr. Reddy's Laboratories stock performance in the past 12 months up to November 2025


Total visits to Dr. Reddy's Laboratories's top domains

Understand Dr. Reddy's Laboratories market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown
drreddys.comdrreddys.com145.9K
msnlabs.commsnlabs.com51.9K
aurigeneservices.comaurigeneservices.com6.6K
See more with Sales Intelligence

Avg. visit duration in Dr. Reddy's Laboratories's top domains

Analyze Dr. Reddy's Laboratories engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
drreddys.comdrreddys.com00:00:39
msnlabs.commsnlabs.com00:00:24
aurigeneservices.comaurigeneservices.com00:02:33
See more with Sales Intelligence

Avg. pageviews on Dr. Reddy's Laboratories's top domains

See how Dr. Reddy's Laboratories keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown
drreddys.comdrreddys.com1.56
msnlabs.commsnlabs.com1.46
aurigeneservices.comaurigeneservices.com2.96
See more with Sales Intelligence

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Dr. Reddy's Laboratories

These are the website technologies, by industry, used by Dr. Reddy's Laboratories top domains

Payment & Currencies (23)

Cart Functionality

Cart Functionality

Advertising (6)

DoubleClick

DoubleClick

Email Services (5)

G Suite

G Suite

Social (5)

Instagram

Instagram

More Technologies

13

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Dr. Reddy's Laboratories

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDr. Reddy’s Laboratories Ltd. is developing Eftilagimod Alfa.This agreement grants Dr Reddy's the rights to develop and commercialise Eftilagimod Alfa in countries outside North America, Europe, Japan, and Greater China.
NewsDr. Reddy’s Laboratories Ltd. partnered with Immutep Limited on Dec 8th '25.Dr Reddy's has signed an exclusive licensing deal with Australia's Immutep to make, develop and distribute the company's cancer treatment, according to a stock exchange filing on Monday.
NewsDr. Reddy’s Laboratories Ltd. received award Notice of Non-Compliance on Oct 29th '25.In a regulatory statement on Wednesday, Dr Reddy's Laboratories stated that the company had received a Notice of Non-Compliance (NON) from Canada's Pharmaceutical Drugs Directorate about its Semaglutide injection application, which requested additional information and clarifications.

See all Dr. Reddy's Laboratories signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.